MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cleveland BioLabs Company Profile (NASDAQ:CBLI)

Consensus Ratings for Cleveland BioLabs (NASDAQ:CBLI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cleveland BioLabs (NASDAQ:CBLI)
Show:
DateFirmActionRatingPrice TargetActions
1/24/2014Cantor FitzgeraldDowngradeBuy -> Hold$4.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/24/2014OppenheimerDowngradeOutperform -> Market Perform$0.75 -> $1.13View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/30/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha